Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring May 12 | 2020Updated Perspective on Nemaura’s CGM; Lifescan and Noom Collaboration; Dario Q1 '20 Earnings UpdatePurchase Blast
$599
Posted in: Autologous, CAR-T, CD19 May 12 | 2020Thoughts on Yescarta vs Kymriah Q1 2020 Sales ComparisonPurchase Blast
$599
Posted in: Allogeneic, Autologous, BCMA, CAR-T, CD19, TCR May 12 | 2020Gilead/Kite Q1 2020 Earnings UpdatePurchase Blast
$599
Posted in: BCMA, CAR-T, CD19 May 12 | 2020Liso-Cel PDUFA 3-Month Delay; BMS Q1 2020 Call SummaryPurchase Blast$599
Posted in: Basal Insulin, Glucose Monitoring May 11 | 2020Nemaura Announces Positive Initial Data from H2H CGM Study; Mylan Q1 '20 Earnings UpdatePurchase Blast
$599
Posted in: GLP-1RA May 08 | 2020High-dose Trulicity Data (AWARD-11) Published in the Journal of the Endocrine SocietyPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, Glucagon May 07 | 2020Novo Q1 '20 Earnings Roadshow; Xeris, Teva, and BD Earnings UpdatesPurchase Blast
$599
Posted in: Bolus Insulin, Glucose Monitoring, Insulin Delivery May 06 | 2020Livongo, MannKind, and Lannett Q1 '20 Earnings Updates; Senseonics Receives Positive BCBS Coverage DecisionsPurchase Blast
$599
Posted in: SGLT2i May 06 | 2020Thoughts on DAPA-HF Approval; Farxiga HCP Website UpdatedPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal May 06 | 2020Semaglutide Positive Ph2 NASH Data; Novo Q1 '20 Earnings UpdatePurchase Blast
$599
Posted in: Autologous, CAR-T, CD19 May 05 | 2020Novartis Oncology Q1 2020 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring May 04 | 2020Dexcom/Ypsomed Partner for CGM Integration; Dexcom G6 Approved In Canada for Hospital Use; Diamyd Topline ResultsPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, SGLT2i May 01 | 2020Sanofi Bs-Aspart Receives Positive CHMP Opinion; No Update on CREDENCEPurchase Blast
$599
Posted in: Insulin Delivery Apr 30 | 2020Tandem Diabetes Care Q1 '20 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring Apr 30 | 2020Roche mySugr Pro Free During COVID-19 PandemicPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Glucagon, SGLT2i Apr 29 | 2020CREDENCE and Sanofi's Bs-Aspart up for CHMP Opinion; CHMP Agenda April 28-30Purchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
